Gilat Logo Full Color.png
Gilat and Hispasat Provided Immediate Satellite Communication to Support Disaster Recovery Efforts After Hurricane Helene
January 15, 2025 07:03 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a world leader in satellite networking technology, solutions, and services, in partnership...
Logo.png
Foresight Signs Agreement to Supply Autonomous Drone Technology in India with Revenue Potential of up to $2.5 Million by 2026
January 14, 2025 09:15 ET | Foresight Autonomous Holdings Ltd.
The cooperation, with a renowned supplier of the Indian Ministry of Defense, entails development and integration of Foresight’s 3D perception solution into autonomous drones. The five-year...
teva_RGB_JPEG.jpg
Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt
January 13, 2025 22:26 ET | Teva Pharmaceutical Industries Ltd
Klinge Biopharma GmbH (Klinge) besitzt die exklusiven weltweiten Vermarktungsrechte für FYB203, Formycons Biosimilar-Kandidat für Eylea®1Die Vereinbarung basiert auf der bewährten und erfolgreichen...
teva_RGB_JPEG.jpg
Teva annonce un partenariat en vue de commercialiser le candidat biosimilaire de Formycon à Eylea® (aflibercept) dans la majeure partie de l’Europe et en Israël
January 13, 2025 22:26 ET | Teva Pharmaceutical Industries Ltd
Klinge Biopharma GmbH (Klinge) détient les droits exclusifs de la commercialisation mondiale de FYB203, le candidat biosimilaire de Formycon, à Eylea®1L’accord repose sur la collaboration éprouvée et...
download.png
Sofwave Medical Reports Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2024 Topline Financial Results
January 13, 2025 08:30 ET | SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide,...
logo
SaverOne Continues its European Expansion: Signs New Distribution Agreement in Germany
January 13, 2025 08:30 ET | SaverOne 2014 Ltd.
Petah Tikvah, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology leader in advanced transportation safety solutions, is pleased to announce a new...
Gilat Logo Full Color.png
Gilat Receives Over $3 Million in Orders to Support LEO Constellations
January 13, 2025 07:04 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today...
teva_RGB_JPEG.jpg
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
January 13, 2025 01:00 ET | Teva Pharmaceutical Industries Ltd
Klinge Biopharma GmbH (Klinge) holds the exclusive global commercialization rights for FYB203, Formycon's biosimilar candidate to Eylea®1Agreement builds on the proven and successful collaboration of...
teva_RGB_JPEG.jpg
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and generalized myasthenia gravis (gMG) in...
Gilat Logo Full Color.png
Gilat to Participate in the 27th Annual Needham Growth Conference on January 14, 2025
January 09, 2025 06:54 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today...